Sensor-based Physiotherapy Intervention With Virtual Reality (SPIN-VR)

January 13, 2026 updated by: Cardiff University

A Randomised Feasibility Study to Evaluate Home-based Personalised Virtual Reality Physiotherapy Rehabilitation Compared to Usual Care in the Treatment of Pain for People With Knee Osteoarthritis

This study is looking at the how the use of non-immersive virtual reality technology can be used to help people that have pain in their knees caused by osteoarthritis. It is a feasibility randomised controlled trial to investigate the feasibility of the use of the intervention by patients in their homes in a larger randomised controlled trial.

The intervention is a non-immersive virtual reality system. Through the use of painless sensors, patients are able to control an animated character on a screen through a series of games that replicates real physiotherapy exercises used to treat knee osteoarthritis. This intervention is being compared to a standard care physiotherapy programme.

As this is a feasibility study, it has no single primary outcome. Instead, the main outcome measures relate to feasibility of the study. This includes; feasibility of recruitment, completeness of outcome measures, the fidelity of healthcare professionals delivering the intervention, the acceptability of the intervention and trial procedures, adverse events, and adherence of the intervention.

Patients are randomised to receive either the intervention or control, and then spend 12-weeks in their assigned treatment. They then receive a 12-week and a 24-week follow up. Patient interviews are offered for those in the intervention arm to collect qualitative data regarding acceptability of the intervention and their participation in the study.

Study Overview

Status

Active, not recruiting

Conditions

Detailed Description

This study is looking at the how the use of non-immersive virtual reality technology can be used to help people that have pain in their knees caused by osteoarthritis. It is a feasibility randomised controlled trial to investigate the feasibility of the use of the intervention by patients in their homes in a larger randomised controlled trial.

The intervention is a non-immersive virtual reality system. This involves sensors that are strapped to the user's arms, legs, head, or chest (depending on the specific exercise). Their movement then controls a character on the screen of either a laptop or a TV. Patients then work through a series of games that replicate physiotherapist exercises. Their performance in the games determines the difficulty of the games, and as patients improve, the exercises get harder. Patients are required to perform these exercises 3 times a week over 12 weeks. During this time, patients have the opportunity to attend clinics with a physiotherapist to review their progress. This intervention is being compared to standard care physiotherapy exercises that patients perform at home in their own time. This programme is prescribed to them by a physiotherapist, and they are followed up regularly over 12 weeks as they perform the programme at home.

This is a feasibility study, and has no single primary outcome or objective. Instead, there are several main outcomes and objectives related to the feasibility of the study and the intervention. The feasibility of recruitment to the study will be measured by the ability to achieve a recruitment of 4 patients per month, over 13 months. The recruitment target is 50. Patient willingness to be randomised will be measured by the reasons for non-consent and withdrawal given by patients. The completeness of outcome measures is measured by the of questionnaires and outcomes completed at 12- and 24-weeks post randomisation. The fidelity of healthcare professionals delivering the intervention will be measured by treatment logs for face-to-face contact, and the observation of two assessments for setting up knee osteoarthritis patients with the intervention. The acceptability of intervention and trial procedures to participants will be measured by interviews with patients and staff about expectations and experience of the intervention, and barriers and facilitators to trial participation. Adverse events experienced by participants from the intervention and trial procedures will also be measure by treatment logs. Adherence to the physiotherapy programme will be measured by the number of times and when patients logged in to the VR games and if follow up consultations were used. There are a variety of secondary objectives and outcome measures. A variety of measurements relating to muscle strength and endurance, aerobic capacity, exercise technique, central pain processing, and self-reported pain mechanisms and moderators will be used to understand how the exercises work to improve pain outcomes. The ability of the intervention to treat knee osteoarthritis will be measured by the OMERACT-OARSI core domain set, a variety of patient-reported outcome measures, pain sensitisation by algometer, and a dynamic balance using a step test.

The target population is adults with knee osteoarthritis who fulfil the NICE and ACR criteria for knee osteoarthritis diagnosis and who have been referred to a physiotherapy clinic.

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cardiff, United Kingdom
        • University Hospital of Wales
      • Cardiff, United Kingdom
        • Cardiff University School of Healthcare Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adults aged 45 or older years
  • Clinical diagnosis of knee osteoarthritis
  • Referred for physiotherapy for clinically diagnosed knee osteoarthritis pain
  • Activity related joint pain
  • Self-reported knee pain on most days for the past 3 months
  • Average pain severity in the past week of 4 or greater on a 10-point numeric rating scale
  • Able to understand written and spoken English
  • Able to provide written informed consent

Exclusion Criteria:

  • Where knee is not identified by the participant as the main source of pain (e.g. comorbid painful conditions, widespread pain).
  • Contraindication to exercise
  • Pain caused by malignancy, fractures, or inflammatory arthritis
  • Has received surgery for their knee pain in the last 12 months
  • Has commenced another new treatment for knee pain, including intra-articular injection, during the preceding 12 weeks
  • Concurrent ongoing treatment by physiotherapy other than the trial interventions
  • Previous knee arthroplasty in either knee
  • Unable to walk without a walking aid
  • Unable or unwilling to engage in either active or control intervention

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: VR-based home physiotherapy
Home-based non-immersive virtual reality using sensors strapped to the users limbs and body. They take part in a variety of games associated with movements of physiotherapy exercises.
VR-based home physiotherapy
Active Comparator: Standard physiotherapy care
Standard care as prescribed by the treating physiotherapist.
Standard physiotherapy care as prescribed by the treating physiotherapist

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility of recruitment
Time Frame: 13-month recruitment period
Ability to achieve a recruitment and randomisation of 4 patients per month, 50 patients within 13 months (number screened, consented, and randomised will be logged; reasons for non-consent or withdrawal will be recorded).
13-month recruitment period
Completeness of outcome measures
Time Frame: 24-week follow up
Number (%) of each questionnaire and mechanistic outcome completed at 12-weeks and 24-weeks post randomisation.
24-week follow up
Fidelity of healthcare professionals delivering intervention
Time Frame: 12-week intervention period
Treatment logs for face-to-face contact, observation of two assessments and training sessions for setting up patients with knee osteoarthritis with the intervention.
12-week intervention period
Acceptability of intervention and trial procedures
Time Frame: 12-week intervention period
Interviews with patients and staff about expectations and experience of the intervention, and barriers and facilitators to trial participation.
12-week intervention period
Adverse events
Time Frame: 24-week follow up
Treatment logs and patient interviews will be used to find issues related to knee symptoms or muscle soreness and falls, and motion sickness, plus any unexpected adverse events.
24-week follow up
Adherence to the intervention
Time Frame: 12-week intervention period
Number of times and date/time of when patients logged in to the VR games and number of physiotherapy follow-up consultations.
12-week intervention period

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluate the processes for exercise mechanism of action at improving pain outcomes
Time Frame: 24-week follow up
A variety of measurements relating to muscle strength and endurance, aerobic capacity, exercise technique, central pain processing, and self-reported pain outcomes and moderators.
24-week follow up
Assess intervention to treat knee osteoarthritis
Time Frame: 24-week follow up
The OMERACT-OARSI core domain set. A variety of patient-reported outcome measures. Pain sensitisation by algometer. Dynamic balance using a step test.
24-week follow up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 4, 2024

Primary Completion (Actual)

January 7, 2026

Study Completion (Estimated)

June 30, 2026

Study Registration Dates

First Submitted

October 10, 2024

First Submitted That Met QC Criteria

October 10, 2024

First Posted (Actual)

October 15, 2024

Study Record Updates

Last Update Posted (Actual)

January 15, 2026

Last Update Submitted That Met QC Criteria

January 13, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Clinical Trials on VR-based home physiotherapy

Subscribe